[{"data":1,"prerenderedAt":27},["ShallowReactive",2],{"program-tumor-targeted-drug-delivery-98360":3},{"id":4,"name":5,"program":6,"department":7,"degree":8,"code":9,"gpa":10,"materials":10,"gre":10,"gmat":10,"ielts":10,"toefl":10,"studyMode":11,"years":10,"unit":12,"tuition":10,"startDate":10,"deadlineDate":10,"description":13,"add01Html":10,"universityId":14,"subjectAreaCode":8,"subjectAreaName":15,"subjectCode":16,"subjectName":17,"qsRank":18,"usNewsRank":18,"timesRank":18,"shanghaiRank":18,"dstatus":11,"createdTime":19,"updatedTime":20,"universityName":21,"unEnglishName":22,"unAbbreviation":23,"unQsRank":24,"unCode":25,"unCity":10,"universityCode":10,"countryCode":26},98360,"肿瘤靶向药物递送","Tumor-Targeted Drug Delivery","Institute of Experimental Molecular Imaging (ExMi)","3","tumor-targeted-drug-delivery-98360",null,1,"CNY","药物递送系统通过减缓其降解、延长血液循环时间、增加靶位点积累和保护健康器官来提高癌症治疗剂的效率。到目前为止，各种药物递送系统已经开发并进行了测试，但其全部潜力尚未得到充分利用。要发挥这一潜力，需要在临床实践、肿瘤生物学和化学技术之间的界面进行密切的跨学科合作。该研究培训小组旨在开发药物递送系统和新的治疗策略，以更有效地治疗肿瘤并减少药物的副作用。将建立创新的生产工艺，以实现药物递送系统的有效、可重复生产。此外，将肿瘤血管系统和肿瘤微环境的个体间和个体内的差异与位点积累、渗透和药物递送系统有效性进行关联。此外，还将研究药理学和物理互补治疗，以增加肿瘤吸收和药物的有效性。",2478,"生命科学与医学","307","药学与药理学",0,"2025-10-25 13:04:51","2026-02-05 13:45:15","亚琛工业大学","RWTH Aachen University","RWTH","0","rwth","de",1772699377643]